ImageneBio, Inc.

8.79+0.09 (+1.03%)

Oct 29, 4:00:02 PM EDT · NasdaqCM · IMA · USD

Upcoming Earnings

Report date

≈ -

Key Stats

Market Cap

98.29M

P/E (TTM)

Basic EPS (TTM)

-4.33

Dividend Yield

Recent Filings

8-K

10/22/25Oct 22, 2025

8-K

10/10/25Oct 10, 2025

8-K

8/5/25Aug 5, 2025

8-K

8/1/25Aug 1, 2025

8-K

7/29/25Jul 29, 2025

About

ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California.

CEO

Ms. Erin Butler

IPO

3/26/2021

Website

https://www.inmagenebio.com

Sector

Healthcare

Industry

Biotechnology